医渡科技有限公司 (02158) 于2026年3月12日向香港联交所提交翌日披露报表。公告显示，公司于同日场内回购1,702,200股普通股，占回购前已发行股份（不包括库存股份）约0.1652%。
本次回购的每股价格介乎5.81港元至5.99港元，总金额10,086,765港元，折合约1,008.68万港元。回购后，公司已发行股份（不包括库存股份）减少至1,028,574,665股，库存股份则增至44,076,000股。
根据公司于2025年8月29日通过的股份回购授权，医渡科技可回购股份总数为106,455,574股。截至目前，公司已累计回购41,184,900股，占回购授权通过当日已发行股份数目的3.8687%。公司确认，本次回购已获得董事会正式批准，并符合香港联交所证券上市规则及相关法律法规。
本公告由公司董事宫盈盈签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.